CD8A and neoplasm: In stage III tumor tissues, however, majority tissues (86.7%, 13/15) had weak expression of CD8 biomarkers, which was significantly different from that of stage III tumors with strong expression of CD8 (13.3%, 2/15, P < 0.01).